Drug Trial Radar · NCT07065305
Clinical Performance and Remineralization Potential of Self- Assembling Peptide P11-4 Containing Fluoride Versus Er, Cr: YSGG Laser Treatment and Micro Tensile Bond Strength of Giomer Restoration in Carious Lesions
Last checked: Nov 20, 2026Latest source record: Jul 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
21
Planned (sponsor's estimate)
Start
Sep 15, 2025
Primary completion
Sep 15, 2026
Study completion Sep 15, 2026
Sponsor
- Lead sponsor
- Al-Azhar UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 15, 2025
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will be performed in two parts, in vivo and in vitro to assess the effect of the remineralization potential of self-assembling peptide P11-4 containing Fluoride on caries-affected dentin compared to untreated caries-affected dentin and the influence of Er, Cr: YSGG Laser treatment.
Conditions
- Remineralization Potential
- Dentin Caries
Interventions
Curodont Repair Fluoride Plus (Self-assembling peptide remineralization agent)P11-4 peptide, fluoride, mild acidic buffer (pH ~4.5) , Credentis AG, SwitzerlandDrug
Pretreatment with Curodont Repair Fluoride Plus (P11-4 + fluoride)
Beautifil II LSDrug
Application of Giomer restorative material following standard adhesive procedures without pretreatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Marginal integrity of restorationsTime frame: 6 months and 12 months
- Clinical longevity of restorationsTime frame: 6 and 12 months
- Overall clinical performance of restorationsTime frame: 6 and 12 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.